Your shopping cart is currently empty

SB-215505 is a subtype-selective 5-HT2B receptor antagonist that inhibits 5-HT2B, 5-HT2A, and 5-HT2C.SB-215505 can be used to study prostate cancer.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $146 | In Stock | In Stock | |
| 5 mg | $363 | In Stock | In Stock | |
| 10 mg | $497 | In Stock | In Stock | |
| 25 mg | $816 | In Stock | In Stock | |
| 50 mg | $1,130 | In Stock | In Stock | |
| 100 mg | $1,530 | - | In Stock | |
| 200 mg | $1,980 | - | In Stock |
| Description | SB-215505 is a subtype-selective 5-HT2B receptor antagonist that inhibits 5-HT2B, 5-HT2A, and 5-HT2C.SB-215505 can be used to study prostate cancer. |
| Targets&IC50 | 5-HT2B Receptor:8.3 (pKi), 5-HT2C Receptor:7.66 (pKi), 5-HT2A Receptor:6.77 (pKi) |
| In vivo | In male Sprague-Dawley rats weighing 230-260 g, SB-215505 (0.1, 0.3, and 1.0 mg/kg; intraperitoneal injection; two doses) dose-dependently increased wakefulness (W) and decreased intermediate stage of sleep (IS), paradoxical sleep (PS), and slow-wave sleep stage 2 (SWS-2)[2]. |
| Synonyms | SB215505, SB 215505 |
| Molecular Weight | 337.8 |
| Formula | C19H16ClN3O |
| Cas No. | 162100-15-4 |
| Smiles | Cc1cc2CCN(C(=O)Nc3cccc4ncccc34)c2cc1Cl |
| Relative Density. | 1.385 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.